Article Details
Retrieved on: 2024-10-03 14:14:38
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses Eligo Bioscience's advancements in CRISPR gene-editing focused on the microbiome, highlighting investment from venture capital funds and strategic investors. It connects biotechnology, genetic engineering, and notable figures like Rodolphe Barrangou and Xavier Duportet.
Article found on: www.biospace.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here